Titre : Extrême-Orient

Extrême-Orient : Questions médicales fréquentes

{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Extrême-Orient : Questions médicales les plus fréquentes", "headline": "Extrême-Orient : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Extrême-Orient : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-06", "dateModified": "2025-03-31", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Extrême-Orient" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Asie", "url": "https://questionsmedicales.fr/mesh/D001208", "about": { "@type": "MedicalCondition", "name": "Asie", "code": { "@type": "MedicalCode", "code": "D001208", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "Z01.252" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Chine", "alternateName": "China", "url": "https://questionsmedicales.fr/mesh/D002681", "about": { "@type": "MedicalCondition", "name": "Chine", "code": { "@type": "MedicalCode", "code": "D002681", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "Z01.252.474.164" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Hong Kong", "alternateName": "Hong Kong", "url": "https://questionsmedicales.fr/mesh/D006723", "about": { "@type": "MedicalCondition", "name": "Hong Kong", "code": { "@type": "MedicalCode", "code": "D006723", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "Z01.252.474.164.450" } } }, { "@type": "MedicalWebPage", "name": "Tibet", "alternateName": "Tibet", "url": "https://questionsmedicales.fr/mesh/D018609", "about": { "@type": "MedicalCondition", "name": "Tibet", "code": { "@type": "MedicalCode", "code": "D018609", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "Z01.252.474.164.900" } } } ] }, { "@type": "MedicalWebPage", "name": "République démocratique populaire de Corée", "alternateName": "Democratic People's Republic of Korea", "url": "https://questionsmedicales.fr/mesh/D056911", "about": { "@type": "MedicalCondition", "name": "République démocratique populaire de Corée", "code": { "@type": "MedicalCode", "code": "D056911", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "Z01.252.474.557.500" } } }, { "@type": "MedicalWebPage", "name": "République de Corée", "alternateName": "Republic of Korea", "url": "https://questionsmedicales.fr/mesh/D056910", "about": { "@type": "MedicalCondition", "name": "République de Corée", "code": { "@type": "MedicalCode", "code": "D056910", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "Z01.252.474.557.750" } } }, { "@type": "MedicalWebPage", "name": "Mongolie", "alternateName": "Mongolia", "url": "https://questionsmedicales.fr/mesh/D008986", "about": { "@type": "MedicalCondition", "name": "Mongolie", "code": { "@type": "MedicalCode", "code": "D008986", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "Z01.252.474.651" } } } ], "about": { "@type": "MedicalCondition", "name": "Extrême-Orient", "alternateName": "Asia, Eastern", "code": { "@type": "MedicalCode", "code": "D005202", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Masoud Dara", "url": "https://questionsmedicales.fr/author/Masoud%20Dara", "affiliation": { "@type": "Organization", "name": "WHO Regional Office for Europe, Copenhagen, Denmark. Electronic address: daram@who.int." } }, { "@type": "Person", "name": "Yakubu Egigogo Raji", "url": "https://questionsmedicales.fr/author/Yakubu%20Egigogo%20Raji", "affiliation": { "@type": "Organization", "name": "Department of Medical Microbiology Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Malaysia." } }, { "@type": "Person", "name": "None None", "url": "https://questionsmedicales.fr/author/None%20None", "affiliation": { "@type": "Organization", "name": "European Board and College of Obstetrics and Gynaecology (EBCOG), European Society of Contraception and Reproductive Health (ESCRH)." } }, { "@type": "Person", "name": "Tzung-Dau Wang", "url": "https://questionsmedicales.fr/author/Tzung-Dau%20Wang", "affiliation": { "@type": "Organization", "name": "Cardiovascular Center and Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei City, Taiwan." } }, { "@type": "Person", "name": "Kazuomi Kario", "url": "https://questionsmedicales.fr/author/Kazuomi%20Kario", "affiliation": { "@type": "Organization", "name": "Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "ALDH2 polymorphism, alcohol intake and the attributable burden of cancer in East Asia: systematic review, meta-analysis, and modeling study.", "datePublished": "2023-06-01", "url": "https://questionsmedicales.fr/article/37268241", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.annepidem.2023.05.013" } }, { "@type": "ScholarlyArticle", "name": "Evaluation of SNPs associated with mammographic density in European women with mammographic density in Asian women from South-East Asia.", "datePublished": "2023-06-20", "url": "https://questionsmedicales.fr/article/37338730", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s10549-023-06984-2" } }, { "@type": "ScholarlyArticle", "name": "Long-range transport of airborne bacteria over East Asia: Asian dust events carry potentially nontuberculous Mycobacterium populations.", "datePublished": "2022-08-17", "url": "https://questionsmedicales.fr/article/36081221", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.envint.2022.107471" } }, { "@type": "ScholarlyArticle", "name": "A review of rural and peri-urban sanitation infrastructure in South-East Asia and the Western Pacific: Highlighting regional inequalities and limited data.", "datePublished": "2022-06-22", "url": "https://questionsmedicales.fr/article/35752101", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ijheh.2022.113992" } }, { "@type": "ScholarlyArticle", "name": "Diachronic shifts in lithic technological transmission between the eastern Eurasian Steppe and northern China in the Late Pleistocene.", "datePublished": "2022-11-03", "url": "https://questionsmedicales.fr/article/36327263", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0275162" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Régions géographiques", "item": "https://questionsmedicales.fr/mesh/D005842" }, { "@type": "ListItem", "position": 3, "name": "Asie", "item": "https://questionsmedicales.fr/mesh/D001208" }, { "@type": "ListItem", "position": 4, "name": "Extrême-Orient", "item": "https://questionsmedicales.fr/mesh/D005202" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Extrême-Orient - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Extrême-Orient", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-18", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Extrême-Orient", "description": "Comment diagnostiquer une infection parasitaire en Extrême-Orient ?\nQuels examens pour le cancer du foie en Asie ?\nComment identifier une tuberculose en Extrême-Orient ?\nQuels tests pour le paludisme en Asie ?\nComment diagnostiquer une hépatite virale ?", "url": "https://questionsmedicales.fr/mesh/D005202?page=5#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Extrême-Orient", "description": "Quels sont les symptômes du choléra ?\nQuels signes d'une infection par le virus Nipah ?\nQuels symptômes de la dengue ?\nQuels symptômes de la grippe aviaire ?\nQuels signes d'une infection à Hantavirus ?", "url": "https://questionsmedicales.fr/mesh/D005202?page=5#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Extrême-Orient", "description": "Comment prévenir le choléra ?\nQuelles mesures pour éviter la dengue ?\nComment prévenir la tuberculose ?\nQuelles précautions pour le paludisme ?\nComment éviter l'hépatite A ?", "url": "https://questionsmedicales.fr/mesh/D005202?page=5#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Extrême-Orient", "description": "Quel traitement pour la tuberculose ?\nComment traiter le paludisme ?\nQuel traitement pour l'hépatite B ?\nComment traiter la dengue ?\nQuel traitement pour le choléra ?", "url": "https://questionsmedicales.fr/mesh/D005202?page=5#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Extrême-Orient", "description": "Quelles complications du choléra ?\nQuelles complications de la dengue ?\nQuelles complications de l'hépatite B ?\nQuelles complications de la tuberculose ?\nQuelles complications du paludisme ?", "url": "https://questionsmedicales.fr/mesh/D005202?page=5#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Extrême-Orient", "description": "Quels sont les facteurs de risque du choléra ?\nQuels facteurs de risque pour la dengue ?\nQuels facteurs de risque pour l'hépatite A ?\nQuels facteurs de risque pour la tuberculose ?\nQuels facteurs de risque pour le paludisme ?", "url": "https://questionsmedicales.fr/mesh/D005202?page=5#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une infection parasitaire en Extrême-Orient ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un diagnostic repose sur des tests sanguins, des analyses de selles et des antécédents de voyage." } }, { "@type": "Question", "name": "Quels examens pour le cancer du foie en Asie ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "L'échographie, la tomodensitométrie et les tests de marqueurs tumoraux sont utilisés." } }, { "@type": "Question", "name": "Comment identifier une tuberculose en Extrême-Orient ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Un test cutané, une radiographie pulmonaire et des cultures de crachats sont nécessaires." } }, { "@type": "Question", "name": "Quels tests pour le paludisme en Asie ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins spécifiques, comme le frottis sanguin, sont utilisés pour le diagnostic." } }, { "@type": "Question", "name": "Comment diagnostiquer une hépatite virale ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins pour détecter les anticorps et les antigènes sont effectués." } }, { "@type": "Question", "name": "Quels sont les symptômes du choléra ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent diarrhée aqueuse, vomissements et déshydratation rapide." } }, { "@type": "Question", "name": "Quels signes d'une infection par le virus Nipah ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, maux de tête, confusion et troubles respiratoires sont fréquents." } }, { "@type": "Question", "name": "Quels symptômes de la dengue ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, douleurs articulaires, éruptions cutanées et saignements peuvent survenir." } }, { "@type": "Question", "name": "Quels symptômes de la grippe aviaire ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, toux, difficultés respiratoires et douleurs musculaires sont typiques." } }, { "@type": "Question", "name": "Quels signes d'une infection à Hantavirus ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, douleurs abdominales, et symptômes respiratoires peuvent se manifester." } }, { "@type": "Question", "name": "Comment prévenir le choléra ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "L'accès à l'eau potable, l'hygiène et la vaccination sont cruciaux." } }, { "@type": "Question", "name": "Quelles mesures pour éviter la dengue ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Éliminer les eaux stagnantes et utiliser des répulsifs contre les moustiques sont efficaces." } }, { "@type": "Question", "name": "Comment prévenir la tuberculose ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "La vaccination BCG et le dépistage précoce des cas sont recommandés." } }, { "@type": "Question", "name": "Quelles précautions pour le paludisme ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser des moustiquaires et des médicaments prophylactiques lors de voyages à risque." } }, { "@type": "Question", "name": "Comment éviter l'hépatite A ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Se laver les mains, consommer de l'eau potable et se faire vacciner sont essentiels." } }, { "@type": "Question", "name": "Quel traitement pour la tuberculose ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Un traitement standard inclut des antibiotiques sur plusieurs mois, comme l'isoniazide." } }, { "@type": "Question", "name": "Comment traiter le paludisme ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments antipaludiques comme la chloroquine ou l'artémisinine sont prescrits." } }, { "@type": "Question", "name": "Quel traitement pour l'hépatite B ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Les antiviraux comme le ténofovir et l'entécavir sont souvent utilisés." } }, { "@type": "Question", "name": "Comment traiter la dengue ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de traitement spécifique ; la réhydratation et le soulagement des symptômes sont essentiels." } }, { "@type": "Question", "name": "Quel traitement pour le choléra ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "La réhydratation orale ou intraveineuse et les antibiotiques sont essentiels." } }, { "@type": "Question", "name": "Quelles complications du choléra ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "La déshydratation sévère et le choc hypovolémique peuvent être mortels." } }, { "@type": "Question", "name": "Quelles complications de la dengue ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Le syndrome de choc dengue et les hémorragies peuvent survenir dans les cas graves." } }, { "@type": "Question", "name": "Quelles complications de l'hépatite B ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "La cirrhose et le cancer du foie sont des complications possibles à long terme." } }, { "@type": "Question", "name": "Quelles complications de la tuberculose ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent la fibrose pulmonaire et la dissémination à d'autres organes." } }, { "@type": "Question", "name": "Quelles complications du paludisme ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "L'anémie sévère, l'insuffisance rénale et le coma peuvent survenir dans les cas graves." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque du choléra ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "L'accès limité à l'eau potable et une mauvaise hygiène augmentent le risque." } }, { "@type": "Question", "name": "Quels facteurs de risque pour la dengue ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Vivre dans des zones tropicales et avoir des moustiques à proximité sont des risques." } }, { "@type": "Question", "name": "Quels facteurs de risque pour l'hépatite A ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Voyager dans des régions à risque et consommer des aliments contaminés augmentent le risque." } }, { "@type": "Question", "name": "Quels facteurs de risque pour la tuberculose ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "La malnutrition, le VIH et le surpeuplement sont des facteurs de risque majeurs." } }, { "@type": "Question", "name": "Quels facteurs de risque pour le paludisme ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Vivre ou voyager dans des zones endémiques et ne pas utiliser de protection contre les moustiques." } } ] } ] }

Sources (5222 au total)

ALDH2 polymorphism, alcohol intake and the attributable burden of cancer in East Asia: systematic review, meta-analysis, and modeling study.

To estimate the burden of alcohol-attributable cancer in East Asian populations accounting for aldehyde dehydrogenase-2 (ALDH2) genotype-specific cancer risk and alcohol exposure.... We conducted a systematic review and meta-analysis of eight databases on cancer risk to derive alcohol dose-response curves by ALDH2 genotype. A simulation-based approach using the Global Burden of Di... We included 34 studies (66,655 participants) from China, Japan, and South Korea in the meta-analysis. Alcohol dose-response curves for liver, esophageal, and oral cavity/pharynx cancer showed an incre... The burden of liver, esophageal, and oral cavity/pharynx cancer attributable to alcohol is underestimated in populations with the ALDH2 genetic polymorphism when compared to current estimates....

Evaluation of SNPs associated with mammographic density in European women with mammographic density in Asian women from South-East Asia.

Mammographic density (MD), after accounting for age and body mass index (BMI), is a strong heritable risk factor for breast cancer. Genome-wide association studies (GWAS) have identified 64 SNPs in 55... Using linear regression adjusting for age, BMI, and ancestry-informative principal components, we evaluated the associations of previously reported MD-associated SNPs with MD in a multi-ethnic cohort ... Of the 61 SNPs available in our data, 21 were associated with MD at a nominal threshold of P value < 0.05, all in consistent directions with those reported in European ancestry populations. Of the rem... Our study confirms the associations of 21 SNPs (19/55 or 34.5% out of all known MD loci identified in women of European ancestry) with area and/or volumetric densities in Asian women, and further supp...

Utility of whole-exome sequencing for patients with multiple congenital anomalies with or without intellectual disability/developmental delay in East Asia population.

Congenital anomalies (CAs) with or without intellectual disability (ID)/developmental delay (DD) comprise a heterogeneous spectrum of diseases that affect approximately 3% of live births worldwide. Re... From August 2018 to July 2019, patients with CAs, with or without ID/DD, after excluding gross chromosomal aberrations, were referred to geneticists in two medical centers. Variant prioritization was ... Forty patients (27 males and 13 females) with CAs were enrolled in the study with a mean age of 4.71 years (range, 0.01-18.2). Pathogenic variants in 14 genes were discovered in 16 patients (three pat... The careful selection of patients by experienced geneticists and the exclusion of chromosomal aberrations raises the positive rate of the molecular diagnosis for CAs to 40%. However, more than half of...

Gender dimensions of youth vulnerability toward access to cigarettes in South-East Asia: Evidence from global youth tobacco survey.

Youths are lured to smoking to make them tobacco customers. Limiting access to tobacco products by youths is a proven strategy to reduce youth tobacco use. This study aimed to examine the burden of ci... The burden along with the physical (methods of obtaining cigarettes), financial (cigarette affordability by pocket money), and illegal (sale to minors) access to cigarettes among school-going boys and... The proportion of youths reporting cigarette smoking was highest in East Timor [boys: 55.57 % (51.93-59.21) and girls: 11.35% (9.12-13.59)] and lowest in Sri Lanka [boys: 2.96% (2.91-3.0) and girls: 0... Contextual cigarette smoking and access to cigarettes by youths despite the legal ban and unaffordability is a concern. Country-specific socio-cultural-economic and legal dimensions need to be examine...

Empagliflozin is associated with lower risk of cardiovascular events and all-cause mortality in routine care in East Asia: Results from the EMPRISE study.

The EMPA-REG OUTCOME® trial demonstrated benefits of empagliflozin, a sodium-glucose cotransporter-2 inhibitor (SGLT2i), on cardiovascular, renal outcomes and all-cause mortality in patients with type... The study included patients ≥18 years with type 2 diabetes initiating empagliflozin or any dipeptidyl peptidase-4 inhibitors (DPP-4i) from large administrative databases in Japan, South Korea, and Tai... The study included 28,712 and 70,233 matched patient pairs for empagliflozin/DPP-4i and SGLT2i/DPP-4i analyses, respectively. The risk of composite outcomes including (i) hospitalization for heart fai... The results suggest that both empagliflozin and SGLT2i compared with DPP-4i are associated with a lower risk of cardiovascular events and all-cause mortality in routine clinical care in East Asia....

Stakeholders' views and perspectives on treatments of visceral leishmaniasis and their outcomes in HIV-coinfected patients in East Africa and South-East Asia: A mixed methods study.

In visceral leishmaniasis (VL) patients coinfected with human immunodeficiency virus (HIV), combination therapy (liposomal amphotericin B infusion and oral miltefosine) is being considered as an alter... In a mixed methods study, we surveyed and interviewed patients, government functionaries, programme managers, health service providers, nongovernmental organizations, researchers, and World Health Org... Mortality and non-serious adverse events were rated as "critical" by respectively the highest (61%) and lowest percentages (47%) of survey participants. Participants viewed clinical cure as essential ...